List of Tables
Table 1. Global NK Cell Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global NK Cell Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global NK Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global NK Cell Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global NK Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global NK Cell Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global NK Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global NK Cell Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. NK Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. NK Cell Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top NK Cell Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global NK Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global NK Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2024)
Table 15. Global NK Cell Therapy Companies Headquarters
Table 16. Date of International Companies Enter into NK Cell Therapy Market
Table 17. Global NK Cell Therapy Companies Product & Service
Table 18. Global NK Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Nektar Therapeutics Corporation Information
Table 20. Nektar Therapeutics Description and Business Overview
Table 21. Nektar Therapeutics NK Cell Therapy Product
Table 22. Nektar Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Nektar Therapeutics Revenue Proportion of NK Cell Therapy by Product in 2024
Table 24. Nektar Therapeutics Revenue Proportion of NK Cell Therapy by Application in 2024
Table 25. Nektar Therapeutics Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 26. Nektar Therapeutics Recent Developments
Table 27. Innate Pharma SA Corporation Information
Table 28. Innate Pharma SA Description and Business Overview
Table 29. Innate Pharma SA NK Cell Therapy Product
Table 30. Innate Pharma SA NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Innate Pharma SA Revenue Proportion of NK Cell Therapy by Product in 2024
Table 32. Innate Pharma SA Revenue Proportion of NK Cell Therapy by Application in 2024
Table 33. Innate Pharma SA Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 34. Innate Pharma SA Recent Developments
Table 35. Affimed Corporation Information
Table 36. Affimed Description and Business Overview
Table 37. Affimed NK Cell Therapy Product
Table 38. Affimed NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Affimed Revenue Proportion of NK Cell Therapy by Product in 2024
Table 40. Affimed Revenue Proportion of NK Cell Therapy by Application in 2024
Table 41. Affimed Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 42. Affimed Recent Developments
Table 43. Chipscreen Biosciences Corporation Information
Table 44. Chipscreen Biosciences Description and Business Overview
Table 45. Chipscreen Biosciences NK Cell Therapy Product
Table 46. Chipscreen Biosciences NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Chipscreen Biosciences Revenue Proportion of NK Cell Therapy by Product in 2024
Table 48. Chipscreen Biosciences Revenue Proportion of NK Cell Therapy by Application in 2024
Table 49. Chipscreen Biosciences Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 50. Chipscreen Biosciences Recent Developments
Table 51. Fate Therapeutics Corporation Information
Table 52. Fate Therapeutics Description and Business Overview
Table 53. Fate Therapeutics NK Cell Therapy Product
Table 54. Fate Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Fate Therapeutics Revenue Proportion of NK Cell Therapy by Product in 2024
Table 56. Fate Therapeutics Revenue Proportion of NK Cell Therapy by Application in 2024
Table 57. Fate Therapeutics Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 58. Fate Therapeutics Recent Developments
Table 59. Glycostem Therapeutics Corporation Information
Table 60. Glycostem Therapeutics Description and Business Overview
Table 61. Glycostem Therapeutics NK Cell Therapy Product
Table 62. Glycostem Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Glycostem Therapeutics Revenue Proportion of NK Cell Therapy by Product in 2024
Table 64. Glycostem Therapeutics Revenue Proportion of NK Cell Therapy by Application in 2024
Table 65. Glycostem Therapeutics Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 66. Glycostem Therapeutics Recent Developments
Table 67. Dragonfly Therapeutics Corporation Information
Table 68. Dragonfly Therapeutics Description and Business Overview
Table 69. Dragonfly Therapeutics NK Cell Therapy Product
Table 70. Dragonfly Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Dragonfly Therapeutics Revenue Proportion of NK Cell Therapy by Product in 2024
Table 72. Dragonfly Therapeutics Revenue Proportion of NK Cell Therapy by Application in 2024
Table 73. Dragonfly Therapeutics Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 74. Dragonfly Therapeutics Recent Developments
Table 75. Kiadis Pharma Corporation Information
Table 76. Kiadis Pharma Description and Business Overview
Table 77. Kiadis Pharma NK Cell Therapy Product
Table 78. Kiadis Pharma NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Kiadis Pharma Revenue Proportion of NK Cell Therapy by Product in 2024
Table 80. Kiadis Pharma Revenue Proportion of NK Cell Therapy by Application in 2024
Table 81. Kiadis Pharma Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 82. Kiadis Pharma Recent Developments
Table 83. NantWorks Corporation Information
Table 84. NantWorks Description and Business Overview
Table 85. NantWorks NK Cell Therapy Product
Table 86. NantWorks NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. NantWorks Revenue Proportion of NK Cell Therapy by Product in 2024
Table 88. NantWorks Revenue Proportion of NK Cell Therapy by Application in 2024
Table 89. NantWorks Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 90. NantWorks Recent Developments
Table 91. Nkarta Therapeutics Corporation Information
Table 92. Nkarta Therapeutics Description and Business Overview
Table 93. Nkarta Therapeutics NK Cell Therapy Product
Table 94. Nkarta Therapeutics NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Nkarta Therapeutics Revenue Proportion of NK Cell Therapy by Product in 2024
Table 96. Nkarta Therapeutics Revenue Proportion of NK Cell Therapy by Application in 2024
Table 97. Nkarta Therapeutics Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 98. Nkarta Therapeutics Recent Developments
Table 99. Fortress Biotech Corporation Information
Table 100. Fortress Biotech Description and Business Overview
Table 101. Fortress Biotech NK Cell Therapy Product
Table 102. Fortress Biotech NK Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Fortress Biotech Revenue Proportion of NK Cell Therapy by Product in 2024
Table 104. Fortress Biotech Revenue Proportion of NK Cell Therapy by Application in 2024
Table 105. Fortress Biotech Revenue Proportion of NK Cell Therapy by Geographic Area in 2024
Table 106. Fortress Biotech Recent Developments
Table 107. North America NK Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America NK Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America NK Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America NK Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific NK Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific NK Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific NK Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific NK Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe NK Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe NK Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe NK Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe NK Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America NK Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America NK Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America NK Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America NK Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa NK Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa NK Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa NK Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa NK Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 127. NK Cell Therapy Key Raw Materials, Industry Status and Trend
Table 128. NK Cell Therapy Key Raw Materials and Upstream Suppliers
Table 129. NK Cell Therapy Clients Status and Trend
Table 130. NK Cell Therapy Typical Clients
Table 131. NK Cell Therapy Distributors
Table 132. NK Cell Therapy Market Trends
Table 133. NK Cell Therapy Market Drivers
Table 134. NK Cell Therapy Market Challenges
Table 135. NK Cell Therapy Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. NK Cell Therapy Product Picture
Figure 2. Global NK Cell Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global NK Cell Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. NK Cell Therapies Product Picture
Figure 5. NK Cell Directed Antibodies Product Picture
Figure 6. Global NK Cell Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global NK Cell Therapy Revenue Market Share by Application in 2024 & 2031
Figure 8. Cancer
Figure 9. Gastrointestinal Diseases
Figure 10. Others
Figure 11. NK Cell Therapy Report Years Considered
Figure 12. Global NK Cell Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global NK Cell Therapy Market Size (2020-2031) & (US$ Million)
Figure 14. Global NK Cell Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global NK Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 16. Global NK Cell Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global NK Cell Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 18. NK Cell Therapies of NK Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 19. NK Cell Directed Antibodies of NK Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 20. NK Cell Therapy Revenue Share by Company (2024)
Figure 21. NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. NK Cell Therapies Revenue Proportion by Company in 2024
Figure 23. NK Cell Directed Antibodies Revenue Proportion by Company in 2024
Figure 24. North America NK Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 25. North America NK Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 26. North America NK Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific NK Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific NK Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific NK Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific NK Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 31. Europe NK Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe NK Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 33. Europe NK Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 34. Europe NK Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 35. Latin America NK Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America NK Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 37. Latin America NK Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 38. Latin America NK Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa NK Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa NK Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa NK Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa NK Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 43. NK Cell Therapy Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of NK Cell Therapy Raw Materials by Region in 2024
Figure 45. NK Cell Therapy Distribution Channels
Figure 46. Global NK Cell Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global NK Cell Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
